Corrigendum to ‘Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma’ [Eur. J. Pharmacol. 738 (2014) 142–152] (European Journal of Pharmacology (2014) 738 (142–152), (S0014299914003963), (10.1016/j.ejphar.2014.05.034));Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma

European Journal of Pharmacology

Volumn 738, Issue , 2014, Pages 142-152

  Gong, Ke ^a   Zhang, Zhenxing ^a   Chen, Yicheng ^a   Shu, Hong Bing ^a   Li, Wenhua ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Autophagy; ERK; Hepatocellular carcinoma; Reactive oxygen species; RIP; Shikonin

Indexed keywords

ACETYLCYSTEINE; BINDING PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REACTIVE OXYGEN METABOLITE; RECEPTOR INTERACTING PROTEIN; SHIKONIN; TIRON; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; NAPHTHOQUINONE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

ACIDIC AUTOPHAGIC VACUOLE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL VACUOLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MORNING DOSAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; ENZYME ACTIVATION; INTRACELLULAR SPACE; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTRACELLULAR SPACE; LIVER NEOPLASMS; MALE; MICE; NAPHTHOQUINONES; REACTIVE OXYGEN SPECIES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902051038     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2020.173462     Document Type: Erratum

References (68)

1. J. Ahn, M. Won, J.H. Choi, Y.S. Kim, C.R. Jung, D.S. Im, M.L. Kyun, K. Lee, K.B. Song, and K.S. Chung Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis Apoptosis: Int. J. Program. Cell Death 18 2013 870 881
2. J.A. Ajani Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction: evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen Cancer 113 2008 945 955
3. I. Arany, J.K. Megyesi, H. Kaneto, P.M. Price, and R.L. Safirstein Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells Am. J. Physiol. Ren. Physiol. 287 2004 F543 549
4. G. Ashrafi, and T.L. Schwarz The pathways of mitophagy for quality control and clearance of mitochondria Cell Death Differ. 20 2013 31 42
5. J. Belghiti, A. Cortes, E.K. Abdalla, J.M. Regimbeau, K. Prakash, F. Durand, D. Sommacale, F. Dondero, M. Lesurtel, A. Sauvanet, O. Farges, and R. Kianmanesh Resection prior to liver transplantation for hepatocellular carcinoma Ann. Surg. 238 2003 885 892 (discussion 892-883)
6. P. Boya, R.A. Gonzalez-Polo, N. Casares, J.L. Perfettini, P. Dessen, N. Larochette, D. Metivier, D. Meley, S. Souquere, T. Yoshimori, G. Pierron, P. Codogno, and G. Kroemer Inhibition of macroautophagy triggers apoptosis Mol. Cell. Biol. 25 2005 1025 1040 (Pubitemid 40165810)
7. J. Bruix, and M. Sherman American association for the study of liver, D. Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
8. S. Cagnol, and J.C. Chambard ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence FEBS J. 277 2010 2 21
9. M.S. Chen, J.Q. Li, Y. Zheng, R.P. Guo, H.H. Liang, Y.Q. Zhang, X.J. Lin, and W.Y. Lau A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma Ann. Surg. 243 2006 321 328 (Pubitemid 43327762)
10. X. Chen, L. Yang, J.J. Oppenheim, and M.Z. Howard Cellular pharmacology studies of shikonin derivatives Phytother. Res. 16 2002 199 209 (Pubitemid 34534943)
11. D.E. Christofferson, and J. Yuan Necroptosis as an alternative form of programmed cell death Curr. Opin. Cell Biol. 22 2010 263 268
12. U. Cillo, A. Vitale, M. Bassanello, P. Boccagni, A. Brolese, G. Zanus, P. Burra, S. Fagiuoli, F. Farinati, M. Rugge, and D.F. D'Amico Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma Ann. Surg. 239 2004 150 159 (Pubitemid 38176347)
13. M. Dank, J. Zaluski, C. Barone, V. Valvere, S. Yalcin, C. Peschel, M. Wenczl, E. Goker, L. Cisar, K. Wang, and R. Bugat Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol. 19 2008 1450 1457
14. W. Declercq, T. Vanden Berghe, and P. Vandenabeele RIP kinases at the crossroads of cell death and survival Cell 138 2009 229 232
15. K. Degenhardt, R. Mathew, B. Beaudoin, K. Bray, D. Anderson, G. Chen, C. Mukherjee, Y. Shi, C. Gelinas, Y. Fan, D.A. Nelson, S. Jin, and E. White Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis Cancer Cell 10 2006 51 64
16. A. Degterev, Z. Huang, M. Boyce, Y. Li, P. Jagtap, N. Mizushima, G.D. Cuny, T.J. Mitchison, M.A. Moskowitz, and J. Yuan Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury Nat. Chem. Biol. 1 2005 112 119
17. A. Degterev, J.L. Maki, and J. Yuan Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase Cell Death Differ. 20 2013 366
18. A.A. Deora, D.P. Hajjar, and H.M. Lander Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras Biochemistry 39 2000 9901 9908 (Pubitemid 30626839)
19. A. Devin, Y. Lin, and Z.G. Liu The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases EMBO Rep. 4 2003 623 627 (Pubitemid 36939955)
20. G.M. Fimia, and M. Piacentini Regulation of autophagy in mammals and its interplay with apoptosis Cell. Mol. Life Sci. 67 2010 1581 1588
21. C. Fleury, B. Mignotte, and J.L. Vayssiere Mitochondrial reactive oxygen species in cell death signaling Biochimie 84 2002 131 141 (Pubitemid 34946949)
22. S.B. Gibson A matter of balance between life and death: targeting reactive oxygen species (ROS)-induced autophagy for cancer therapy Autophagy 6 2010 835 837
23. K. Gong, and W. Li Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: a potential new treatment for hepatocellular carcinoma Free Radic. Biol. Med. 51 2011 2259 2271
24. C. Gordy, and Y.W. He The crosstalk between autophagy and apoptosis: where does this lead? Protein Cell 3 2012 17 27
25. D. Gozuacik, and A. Kimchi Autophagy as a cell death and tumor suppressor mechanism Oncogene 23 2004 2891 2906 (Pubitemid 38638851)
26. W. Han, J. Xie, Y. Fang, Z. Wang, and H. Pan Nec-1 enhances shikonin-induced apoptosis in leukemia cells by inhibition of RIP-1 and ERK1/2 Int. J. Mol. Sci. 13 2012 7212 7225
27. M. Hayashi Pharmacological studies on crude plant drugs, Shikon and Tooki 2. Shikonin and acetylshikonin Folia Pharmacol. Jpn. 73 1977 193 203 (Pubitemid 8148176)
28. P.C. Hsu, Y.T. Huang, M.L. Tsai, Y.J. Wang, J.K. Lin, and M.H. Pan Induction of apoptosis by shikonin through coordinative modulation of the Bcl-2 family, p27, and p53, release of cytochrome c, and sequential activation of caspases in human colorectal carcinoma cells J. Agric. Food Chem. 52 2004 6330 6337
29. R.C. Kane, A.T. Farrell, R. Madabushi, B. Booth, S. Chattopadhyay, R. Sridhara, R. Justice, and R. Pazdur Sorafenib for the treatment of unresectable hepatocellular carcinoma Oncologist 14 2009 95 100
30. A.C. Kimmelman The dynamic nature of autophagy in cancer Genes Dev. 25 2011 1999 2010
31. D.A. Kubli, and A.B. Gustafsson Mitochondria and mitophagy: the yin and yang of cell death control Circ. Res. 111 2012 1208 1221
32. H.S. Lee, J.S. Kim, I.J. Choi, J.W. Chung, J.H. Park, and C.Y. Kim The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study Cancer 79 1997 2087 2094 (Pubitemid 27227372)
33. J.H. Lee, K.M. Jung, I.H. Bae, S. Cho, D.B. Seo, S.J. Lee, Y.H. Park, and K.M. Lim Anti-inflammatory and barrier protecting effect of Lithospermum erythrorhizon extracts in chronic oxazolone-induced murine atopic dermatitis J. Dermatol. Sci. 56 2009 64 66
34. X. Li, J. Yan, L. Wang, F. Xiao, Y. Yang, X. Guo, and H. Wang Beclin1 inhibition promotes autophagy and decreases gemcitabine-induced apoptosis in Miapaca2 pancreatic cancer cells Cancer Cell Int. 13 2013 26
35. Y. Lin, A. Devin, A. Cook, M.M. Keane, M. Kelliher, S. Lipkowitz, and Z.G. Liu The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase Mol. Cell Biol. 20 2000 6638 6645
36. M.E.-m Liu Yan, and Jiati-rehemu Ni Protective effects of Arnebia euchroma (Royle) johnston extracts against CCl4-induced acute liver injuqry in mice Lishizhen Med. Mater. Med. Res. 9 2006 1676 1678
37. S. Long, Y. GuangZhi, G. BaoJie, X. Wei, H. YanYong, W. YingLi, Z. Yang, and L. LiHua Shikonin derivatives protect immune organs from damage and promote immune responses in vivo in tumour-bearing mice Phytother. Res. 26 2012 26 33
38. L.Y. Mahmut-Maierdan, Hujia-Gulixian, and Guo-qing Zhang The hepatoprotective effects of Arnebia euchroma (Royle) Johnston extracts against alcohol-induced acute liver injury in mice Chin. Rem. Clin. 7 2007 284 286
39. M.C. Maiuri, E. Zalckvar, A. Kimchi, and G. Kroemer Self-eating and self-killing: crosstalk between autophagy and apoptosis Nat. Rev. Mol. Cell Biol. 8 2007 741 752 (Pubitemid 47312826)
40. X. Mao, C.R. Yu, W.H. Li, and W.X. Li Induction of apoptosis by shikonin through a reactive oxygen species/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells Cell Res. 18 2008 879 888
41. W. Martinet, P. Agostinis, B. Vanhoecke, M. Dewaele, and G.R. De Meyer Autophagy in disease: a double-edged sword with therapeutic potential Clin. Sci. 116 2009 697 712
42. R. Mathew, C.M. Karp, B. Beaudoin, N. Vuong, G. Chen, H.Y. Chen, K. Bray, A. Reddy, G. Bhanot, C. Gelinas, R.S. Dipaola, V. Karantza-Wadsworth, and E. White Autophagy suppresses tumorigenesis through elimination of p62 Cell 137 2009 1062 1075
43. R. Mathew, S. Kongara, B. Beaudoin, C.M. Karp, K. Bray, K. Degenhardt, G. Chen, S. Jin, and E. White Autophagy suppresses tumor progression by limiting chromosomal instability Genes Dev. 21 2007 1367 1381 (Pubitemid 46871040)
44. R. Mathew, and E. White Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night Curr. Opin. Genet. Dev. 21 2011 113 119
45. R. Min, J. Tong, Y. Wenjun, D. Wenhu, Z. Xiaojian, H. Jiacai, Z. Jian, C. Wantao, and Z. Chenping Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway Phytother. Res. 22 2008 407 415 (Pubitemid 351397447)
46. A. Obed, T.Y. Tsui, A.A. Schnitzbauer, M. Obed, H.J. Schlitt, H. Becker, and T. Lorf Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified? Langenbecks Arch. Surg. 393 2008 141 147
47. Organization, W.H., 2006. Cancer.
48. V.P. Papageorgiou, A.N. Assimopoulou, E.A. Couladouros, D. Hepworth, and K.C. Nicolaou The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products Angew. Chem. Int. Ed. 38 1999 270 301
49. H. Pelicano, D. Carney, and P. Huang Reactive oxygen species stress in cancer cells and therapeutic implications Drug Resist. Updates: Rev. Comment. Antimicrob. Anticancer Chemother. 7 2004 97 110 (Pubitemid 38736063)
50. B. Ravikumar, S. Sarkar, J.E. Davies, M. Futter, M. Garcia-Arencibia, Z.W. Green-Thompson, M. Jimenez-Sanchez, V.I. Korolchuk, M. Lichtenberg, S. Luo, D.C. Massey, F.M. Menzies, K. Moreau, U. Narayanan, M. Renna, F.H. Siddiqi, B.R. Underwood, A.R. Winslow, and D.C. Rubinsztein Regulation of mammalian autophagy in physiology and pathophysiology Physiol. Rev. 90 2010 1383 1435
51. J.T. Samuelsen, J.E. Dahl, S. Karlsson, E. Morisbak, and R. Becher Apoptosis induced by the monomers HEMA and TEGDMA involves formation of reactive oxygen species and differential activation of the MAP-kinases p38, JNK and ERK Dent. Mater.: Off. Publ. Acad. Dent. Mater. 23 2007 34 39 (Pubitemid 44895421)
52. U. Sankawa, Y. Ebizuka, T. Miyazaki, Y. Isomura, H. Otsuka, S. Shibata, M. Inomata, and F. Fukuoka Anti-tumor activity of shikonin and its derivatives Chem. Pharm. Bull. 25 1977 2392 2395 (Pubitemid 8196664)
53. R. Scherz-Shouval, and Z. Elazar Regulation of autophagy by reactive oxygen species: physiology and pathology Trends Biochem. Sci. 36 2011 30 38
54. L. Su, L. Liu, Y. Wang, G. Yan, and Y. Zhang Long-term systemic toxicity of shikonin derivatives in Wistar rats Pharm. Biol 2013
55. Z. Sun, L. Ming, X. Zhu, and J. Lu Prevention and control of hepatitis B in China J. Med. Virol. 67 2002 447 450
56. A. Takamura, M. Komatsu, T. Hara, A. Sakamoto, C. Kishi, S. Waguri, Y. Eishi, O. Hino, K. Tanaka, and N. Mizushima Autophagy-deficient mice develop multiple liver tumors Genes Dev. 25 2011 795 800
57. A.T. Ting, F.X. Pimentel-Muinos, and B. Seed RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis EMBO J. 15 1996 6189 6196 (Pubitemid 26397891)
58. B.R. Underwood, S. Imarisio, A. Fleming, C. Rose, G. Krishna, P. Heard, M. Quick, V.I. Korolchuk, M. Renna, S. Sarkar, M. Garcia-Arencibia, C.J. O'Kane, M.P. Murphy, and D.C. Rubinsztein Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease Hum. Mol. Genet. 19 2010 3413 3429
59. P. Vandenabeele, S. Grootjans, N. Callewaert, and N. Takahashi Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models Cell Death Differ. 20 2013 185 187
60. C. Vindis, M.H. Seguelas, S. Lanier, A. Parini, and C. Cambon Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase Kidney Int. 59 2001 76 86 (Pubitemid 32055216)
61. Z. Wang, T. Liu, L. Gan, T. Wang, X. Yuan, B. Zhang, H. Chen, and Q. Zheng Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity Eur. J. Pharmacol. 643 2010 211 217
62. E. White, and R.S. DiPaola The double-edged sword of autophagy modulation in cancer Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 15 2009 5308 5316
63. Z. Wu, L. Wu, L. Li, S. Tashiro, S. Onodera, and T. Ikejima p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells J. Pharmacol. Sci. 94 2004 166 176 (Pubitemid 38405131)
64. Z. Wu, L.J. Wu, L.H. Li, S. Tashiro, S. Onodera, and T. Ikejima Shikonin regulates HeLa cell death via caspase-3 activation and blockage of DNA synthesis J. Asian Nat. Prod. Res. 6 2004 155 166 (Pubitemid 38833171)
65. X. Xie, L. Le, Y. Fan, L. Lv, and J. Zhang Autophagy is induced through the reactive oxygen species-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition Autophagy 8 2012 1071 1084
66. J. Yamamoto, S. Okada, K. Shimada, T. Okusaka, S. Yamasaki, H. Ueno, and T. Kosuge Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection Hepatology 34 2001 707 713 (Pubitemid 32927994)
67. C.C. Yeh, H.M. Kuo, T.M. Li, J.P. Lin, F.S. Yu, H.F. Lu, J.G. Chung, and J.S. Yang Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24) in vivo 21 2007 1011 1019
68. P. Zhang, Y.Z. Wang, E. Kagan, and J.C. Bonner Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK J. Biol. Chem. 275 2000 22479 22486 (Pubitemid 30621836)